NLS Pharmaceutics AG kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$2.64
Açılış fiyatı
$2.7
Günün Aralığı
$2.64 - $2.84
52 haftalık aralık
$0.76 - $41.5
İşlem hacmi
113.9K
Ort.Hacim
398.5K
EPS (TTM)
-17.40
Dividend yield
--
Piyasa Değeri
$14.4M
NLSP nedir?
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.